| Equatorial Resources Limited (EQX) ORDINARY FULLY PAID |
Materials |
$26 |
September 2025 Quarterly Report
|
29 Oct 2025 9:05AM |
$0.225 |
$0.200 |
fallen by
11.11%
|
|
EQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Equatorial Resources Limited (Equatorial) reported a strong financial position with approximately $8.7 million in cash as of 30 September 2025.
- Equatorial's subsidiary, EEPL, is involved in an arbitration case against the Republic of Congo due to disputes over iron ore projects.
- The arbitration hearing is scheduled to take place in Washington, D.C., from 7 to 12 November 2025.
- Equatorial is claiming damages ranging from US$395 million to US$1,254 million from Congo.
- The company is also seeking clarification from Guinea regarding the status of its exploration permits after a reported cancellation.
- Despite legal disputes, Equatorial remains committed to its investments in Congo and Guinea.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryder Capital Limited (RYD) ORDINARY FULLY PAID |
Financials |
$164 |
Update - Notification of buy-back - RYD
|
29 Oct 2025 9:04AM |
$1.700 |
$2.040 |
risen by
20%
|
|
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$3,131 |
Trading Halt
|
29 Oct 2025 9:04AM |
$1.030 |
$1.220 |
risen by
18.45%
|
|
L1G - Price-sensitive ASX Announcement
Full Release
Key Points
- L1 Group Limited (ASX: L1G) requested a trading halt on its securities.
- The halt is pending an announcement related to an equity raising through an institutional placement and a share purchase plan.
- The trading halt will remain until the completion of the placement announcement or the commencement of trading on 31 October 2025.
- The company is not aware of any reasons why the trading halt should not be granted.
- The request was made in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$42 |
Quarterly update & Appendix 4C webinar
|
29 Oct 2025 9:04AM |
$0.042 |
$0.200 |
risen by
376.19%
|
|
| Odyssey Gold Ltd (ODY) ORDINARY FULLY PAID |
Materials |
$46 |
September 2025 Quarterly Report
|
29 Oct 2025 9:03AM |
$0.031 |
$0.033 |
risen by
6.45%
|
|
ODY - Price-sensitive ASX Announcement
Full Release
Key Points
- Odyssey Gold Limited continues to focus on the Tuckanarra Gold Project, located in the Murchison Goldfields of Western Australia.
- A Mining Technical Study was completed to assess mining options at Tuckanarra and process at the nearby Burnakura Processing Plant.
- The study results were positive, leading to a Scoping Study to be undertaken next.
- Preliminary metallurgical testwork showed high recoveries, with LeachWELLTM recoveries of 95-97% across samples.
- A 5,232-metre reverse circulation (RC) infill drilling program was completed at Tuckanarra to upgrade Inferred Mineral Resources to Indicated Mineral Resources.
- Significant drilling intersections included 20m @ 7.1g/t Au from 47m, among others.
- A new 5,000-metre RC drilling program commenced, focused on the Highway deposit and the new Cable hanging wall structure.
- The company raised $4 million through a share placement to fund ongoing exploration and development.
- Total Mineral Resource Estimate for Tuckanarra stands at 5.14 million tonnes at 2.5 g/t Au for 407,000 ounces of gold.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$62 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2025 9:03AM |
$0.125 |
$0.120 |
fallen by
4%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Narmafotinib clinical trials show a 33% objective response rate in metastatic pancreatic cancer.
- Ethics approval received for a trial combining narmafotinib with FOLFIRINOX in Australia.
- Successful capital raise of $27.5 million, funding operations into 2027.
- Cash balance of $29.2 million as of September 2025, enhanced by a $3.8 million tax incentive refund.
- Total payments of $172,500 to related parties for director fees and salaries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$70 |
Appendix 4C and Market Update
|
29 Oct 2025 9:02AM |
$0.096 |
$0.215 |
risen by
123.96%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences completed a successful capital raise of $3.75 million, oversubscribed by institutional and sophisticated investors.
- ColoSTAT® manufacturing validation was completed by QUANSYS, and the NATA accreditation process is underway.
- The company achieved strategic partnerships for geneTypeTM with key organizations, including a major Australian pathology provider and the Know Your Lemons Foundation.
- ColoSTAT® showed a sensitivity of 91% and a high negative predictive value of 98% for detecting colorectal cancer in high-risk individuals.
- Strong operating performance in Q1 FY26, with progress towards FY26 objectives and commercial readiness of ColoSTAT®.
- Rhythm’s product portfolio focuses on disease screening through minimally-invasive detection methods and personalized health management.
- Significant progress made in geneTypeTM revenue growth, over 100% quarter-on-quarter, supported by strategic distribution partnerships.
- Upcoming RDTI refund expected to further support operations and financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$101 |
Update - Notification of buy-back - CAM
|
29 Oct 2025 9:01AM |
$0.680 |
$0.705 |
risen by
3.68%
|
|
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
ADS - Price-sensitive ASX Announcement
Full Release
Key Points
- Net operating cash outflow for the quarter was $0.57M.
- Total capital raised during the quarter was $989,000.
- Cash receipts from customers were $3.42M, a 21% increase from the previous quarter.
- Annualized salary cost savings of $5.24M achieved.
- Cash at the end of the quarter was $1.89M.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$45 |
Update - Notification of buy-back - EPY
|
29 Oct 2025 9:00AM |
$0.210 |
$0.175 |
fallen by
16.67%
|
|
| Tyranna Resources Limited (TYX) ORDINARY FULLY PAID |
Materials |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
TYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Application for extension of Namibe Project term until October 2026.
- Focus on caesium mineral pollucite at Muvero and Loop Prospects.
- Acquisition of 75% shareholding in AGFC E Filos, LDA.
- Completion of initial steps to acquire 70% interest in Maongo Copper-Gold Project.
- Cash reserves of $2.55 million and no debt at quarter-end.
- Net cash outflow for operations was $0.667 million.
- Payments to related parties totaled $175,000.
- Significant exploration and evaluation expenses reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$66 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.031 |
$0.021 |
fallen by
32.26%
|
|
LMG - Price-sensitive ASX Announcement
Full Release
Key Points
- EPA Victoria reissued the Pilot Project Licence for LMG.
- Successful production of magnesium oxide at the Demonstration Plant.
- Completion of $6M placement and $4M rights issue for supporting operations.
- U.S. Export Import Bank issued a Letter of Interest for AUD $200M financing.
- Ongoing development of a 10,000 tpa Commercial Plant in Victoria.
- Legal confirmation for importing feedstock to Malaysia for the 'Mega' Plant.
- Proceeds from surplus land sale and R&D rebate expected to aid financial stability.
- LMG’s projects focus on recycling, reducing landfill, and low CO2 emissions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$711 |
Government confirms Kangankunde unaffected by Export Order
|
29 Oct 2025 9:00AM |
$0.305 |
$0.425 |
risen by
39.34%
|
|
LIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Lindian Resources Limited receives confirmation from Malawi Government that Kangankunde mine is unaffected by export order.
- Kangankunde Rare Earths Project will not export raw minerals but a monazite concentrate.
- The project has strong infrastructure, community, and government support.
- Lindian has a strategic partnership with Iluka Resources Ltd and funding for Kangankunde.
- The Executive Order No. 2 of 2025 mandates local beneficiation of minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,578 |
Notification of cessation of securities - MFG
|
29 Oct 2025 8:59AM |
$10.080 |
$9.390 |
fallen by
6.85%
|
|
| Fitzroy River Corporation Ltd (FZR) ORDINARY FULLY PAID |
Energy |
$18 |
Quarterly Activities & Cashflow Report
|
29 Oct 2025 8:59AM |
$0.170 |
$0.170 |
fallen by
0%
|
|
FZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Royalty income of $171,609 received during the quarter.
- Total royalty receipts for the year to 30 September 2025 were $619,145.
- Buru Royalty involves a 2-year extension for a Production Licence over the Rafael Gas and Condensate Field.
- Bowden’s Silver Project development information submitted to the New South Wales Department.
- Snowy River Gold Project funded through a $150 million equity raise.
- Company faced risks from oil and gas price volatility due to geopolitical tensions.
- Corporate and administrative costs amounted to $142,342 for the quarter.
- Report approved for release by Fitzroy River Corporation Ltd's Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,578 |
Update - Notification of buy-back - MFG
|
29 Oct 2025 8:59AM |
$10.080 |
$9.390 |
fallen by
6.85%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$452 |
Update - Notification of buy-back - RG8
|
29 Oct 2025 8:58AM |
$2.410 |
$2.970 |
risen by
23.24%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$49 |
Quarterly Business Update and Appendix 4C - September 2025
|
29 Oct 2025 8:58AM |
$0.343 |
$0.345 |
risen by
0.73%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ received a worldwide license for an exosomal ovarian cancer biomarker.
- Published data on the efficacy of CAR-T-exosomes in cancer treatment.
- Completed a $9.5 million placement to fund developments.
- Reported $4.8 million in cash with a net operating cash outflow of $1.65 million.
- Advancing ovarian cancer test and CAR-NK-exosome therapy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$6,747 |
Update - Notification of buy-back - WOR
|
29 Oct 2025 8:58AM |
$14.300 |
$13.330 |
fallen by
6.78%
|
|
| Lightning Minerals Ltd (L1M) ORDINARY FULLY PAID |
Materials |
$6 |
Completion of Drilling at Mt Turner Gold Project
|
29 Oct 2025 8:58AM |
$0.049 |
$0.020 |
fallen by
59.18%
|
|
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$254 |
HK Distributor Signed as Remplir Expands in the Asian Market
|
29 Oct 2025 8:57AM |
$1.120 |
$0.935 |
fallen by
16.52%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell Limited appoints MontsMed as exclusive distributor for Remplir in Hong Kong.
- First surgical cases and sales in Hong Kong expected soon.
- Asia is a strategic pillar valued at over US$3.5 billion in total addressable market.
- Hong Kong approval provides access to Greater Bay Area with a population of around 100 million.
- Momentum building in Singapore with Device Technologies Asia and pending sales in Thailand by 2026.
- Australian-based Commercial Director appointed to oversee commercialization and distributor management in Asia.
- Orthocell is executing a global commercialization strategy with a strong balance sheet of over $50 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
29 Oct 2025 8:56AM |
$1.920 |
$1.950 |
risen by
1.56%
|
|
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$61 |
Notification of Cancellation of Shares - Form 484
|
29 Oct 2025 8:56AM |
$0.745 |
$0.730 |
fallen by
2.01%
|
|
| Ausbil Active Dividend Income Fund - Active ETF (DIVI) |
Financials |
$581 |
Estimated Distribution - October 2025
|
29 Oct 2025 8:56AM |
$11.320 |
$11.750 |
risen by
3.80%
|
|
| Kalina Power Limited (KPO) ORDINARY FULLY PAID |
Utilities |
$38 |
Notice of Annual General Meeting / Proxy Form
|
29 Oct 2025 8:55AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
Call 1300 880 160
Start a chat
Schedule a call
